Wearable Devices Could Enable Early Detection of Cytokine Release Syndrome in CAR-T Therapy Patients
In a groundbreaking study published in JCI Insight, researchers at the Icahn School of Medicine at Mount Sinai have revealed ...
In a groundbreaking study published in JCI Insight, researchers at the Icahn School of Medicine at Mount Sinai have revealed ...
Pancreatic cancer remains one of the most aggressive malignancies globally, with a historically poor prognosis and limited therapeutic options. Recent ...
In a groundbreaking study poised to redefine our understanding of therapeutic resistance in bladder cancer, researchers have unveiled the pivotal ...
In a groundbreaking study, researchers have harnessed the potential of bioorthogonal chemistry to develop tumour-specific proteolysis-targeting chimeras (PROTACs) and nanoparticles ...
In a groundbreaking advancement poised to reshape the therapeutic landscape of colorectal cancer (CRC), researchers have uncovered pivotal insights into ...
In a groundbreaking advancement in cancer immunotherapy, a novel approach employing collagen-binding IL-12-armored STEAP1 CAR-T cells has shown remarkable potential ...
In the evolving battlefield of oncology, the emergence of cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors has ignited a beacon ...
More than thirty years ago, the U.S. Food and Drug Administration (FDA) made a landmark decision by approving Bacillus Calmette-Guérin ...
In recent years, the landscape of cancer treatment has been dramatically reshaped by the advent of immunotherapy, a strategy that ...
Immune checkpoint inhibitors are a groundbreaking innovation in the field of cancer therapy, significantly altering the way we approach treatment ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine